#gastriccancer
Mitochondrial redox balance could reveal new cancer clues.
This pan-cancer study links SLC25A39 to tumor progression, immune checkpoints and #immunotherapy response, highlighting its #biomarker potential. #GastricCancer
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
September 24, 2026 at 2:54 PM
Keynote speaker Dr. Parry Guilford breaks down the similarities between #lobular #breastcancer and diffuse #gastriccancer via a hereditary #CDH1 mutation. #ILCSymposium. Good to know as we enter Hereditary Cancer Awareness Week! #bcsm @lobularbca.bsky.social
September 24, 2026 at 6:45 PM
Inspiring meeting with over 80 community health workers, talking about my #gastricCancer research & providing information & resources to improve early detection + patient outcomes. Thanks @acscan.bsky.social @medicalcollegeofwi.bsky.social #cancerResearch @mcwpharm-tox.bsky.social
March 26, 2026 at 10:13 PM
Protoporphyrin IX-Derived Ruthenium(II) Complexes for Photodynamic Therapy in Gastric Cancer Cells | Inorganic Chemistry pubs.acs.org/doi/10.1021/... Mellitzer, Le Lagadec, and co-workers @InorgChem #ruthenium #protoporphyrinIX #PDT #PS #ROS #apoptosis #CHOP #gastriccancer
May 3, 2025 at 3:50 AM
NEW @unibirmingham.bsky.social researchers uncovered novel #microbiome based #biomarkers that could transform early detection & treatment of #gastrointestinal diseases like #gastriccancer #colorectalcancer and inflammatory bowel disease #IBD translational-medicine.biomedcentral.com/articles/10....
May 29, 2025 at 11:05 AM
Gastric cancer hijacks nociceptive neurons to fuel tumor growth and metastasis, revealing a potential therapeutic target in cancer–nerve interactions #GastricCancer #Sensoryneuron
Nociceptive neurons promote gastric tumour progression via a CGRP–RAMP1 axis - Nature
Functional connectivity between gastric cancer cells and sensory neurons offers a potential therapeutic target.
www.nature.com
March 14, 2025 at 7:40 PM

🩺 H. pylori Testing in Cancer Screening

Adding H. pylori testing to FIT didn’t reduce gastric cancer mortality in a large trial. Focus on proven cancer screening methods for population health impact.

#CancerPrevention #GastricCancer #Oncology
@oncoalert.bsky.social

doi:10.1001/jama.2024.14887
November 20, 2024 at 1:17 PM
Coming up at #GI26, Dr. Geoffrey Ku will give a medical oncologist's perspective on the role of local and systemic treatments in metastatic #gastriccancer and #gastroesophagealcancer @mskcancercenter.bsky.social #GICancers @ascocancer.bsky.social

3:45 – 5 p.m. PST | Level 3, Room 3001
January 8, 2026 at 9:26 PM
Guilford breaks down clinical management of hereditary diffuse #gastriccancer which is intense. Patients often have their stomachs removed, which comes w/ many adverse effects (& a few bennies, he noted, tongue firmly in cheek). #ILCSymposium #HDGC #lobmob #bcsm
September 24, 2026 at 7:02 PM
This hits close to home - lost my Aunt to NF1 complications #BrainTumours #GastricCancer
July 30, 2025 at 2:39 PM
🐭 In a mouse model of Helicobacter infection, loss of endogenous glucocorticoids drove inflammation, autoimmunity and dysplasia even after bacterial clearance 🔗 linking immune dysregulation to cancer risk.
➡️ https://ow.ly/y4Fo50YIun2
🏷️ #AIG #GastricCancer #Immunology
April 14, 2026 at 4:01 PM
SCI Member Hanlee Ji & others found that #GastricCancer precursors exhibit variable progression rates. A 26-gene panel was identified, linked to advanced lesions, suggesting immature intestinal cells play a key role in carcinogenesis. www.nature.com/articles/s41...
March 3, 2025 at 5:00 PM
NEW PAPER ALERT: ESOPEC trial on Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer

oncodaily.com/oncolibrary/...

#Cancer #EsophagealCancer #GastricCancer #NEJM #NewPaperAlert #NewTrials #Medicine #Health
NEW PAPER ALERT: ESOPEC trial on Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer - OncoDaily
New Paper Alert: Summary of The ESOPEC trial in NEJM comparing perioperative FLOT vs chemoradiotherapy in esophageal cancer
oncodaily.com
February 5, 2025 at 6:29 PM
Collaborators Eric Van Cutsem, Yelena Janjigian, & Kohei Shitara caught up at #GI26. Dr. Janjigian shared a trial in progress of a 1st line combination for HER2-low #gastriccancer, gastroesophageal junction adenocarcinoma, or esophageal adenocarcinoma. @mskcancercenter.bsky.social.

bit.ly/4aSddGo
January 8, 2026 at 10:58 PM
Our March issue is now live: www.thelancet.com/issue/S1470-...

This issue includes papers on #ProstateCancer, #GastricCancer, #RenalCellCarcinoma, #Melanoma, #BreastCancer, #ThymicCarcinoma, and more

Our Editorial: Personalised cancer vaccines and new regulatory struggles
March 5, 2025 at 9:26 AM
This study on advanced #GastricCancer showed that combining #radiomics with clinical data improves prediction of pathological responses to neoadjuvant #chemotherapy.
February 26, 2025 at 11:00 AM
Gastric cancer is the fifth most diagnosed #cancer and the fifth leading cause of cancer-related deaths worldwide.

📌 This Review summarizes the epidemiology, pathophysiology, diagnosis, and management of #GastricCancer.

ja.ma/49SfP69
February 3, 2026 at 4:45 PM
ESMO Preceptorship on Gastric Cancer in Lisbon 🇵🇹:

✅ HER2, CLDN18.2, MSI-H
✅ New therapeutic strategies
✅ Made me feel personally attacked by every life choice I’ve ever made 🍷

#GastricCancer #ESMO
June 28, 2026 at 12:46 PM